Please assess the completion status of the following clinical trial:

Trial Title: Trabeculectomy With Ologen

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Primary open-angle glaucoma with progression of visual field loss and/or uncontrolled intraocular pressure levels with medication.~* Indication for trabeculectomy with mitomycin-C~Exclusion Criteria:~* Unability to discontinue oral anticoagulants~* Difficulty in reading or speaking Dutch~* Previous ocular surgery (cataract surgery allowed)~* Pregnant and breastfeeding women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ologen implantation (single arm) (Type: EXPERIMENTAL): Ologen implantation as an adjunctive to trabeculectomy

Based on this trial design, predict the completion outcome and termination type (if applicable).